American Vanguard Corporation — Q1 2012 Form 10-Q
Business context and period. The filing covers the three months ended March 31, 2012, compared with the same period in 2011. American Vanguard sells crop-protection and non-crop products and reports one operating segment. Financial amounts below are in millions of dollars unless noted otherwise.
Financial performance
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Net sales | $87.3 | $66.0 |
| Gross profit / gross margin | $37.4 / 42.8% | $26.9 / 40.8% |
| Operating income / operating margin | $14.4 / 16.5% | $9.2 / 13.9% |
| Net income | $8.7 | $5.0 |
| Diluted EPS | $0.31 | $0.18 |
| Net cash used in operating activities | $(7.6) | $(10.5) |
| Capital expenditures | $5.7 | $0.9 |
- Sales rose 32%. Crop sales increased 39% to $79.9 million; non-crop sales declined 13% to $7.4 million. Insecticide sales grew 43% and herbicide/fungicide/fumigant sales grew 39%.
- Export sales increased to $17.7 million from $8.1 million. Management attributed crop-sector strength to favorable planting conditions, strong agricultural demand and commodity prices, increased pest activity, and demand for soil insecticides.
- Gross margin improved by about 2 percentage points, which management attributed partly to manufacturing activity and improved overhead recovery. Operating expenses rose $5.3 million to $23.0 million, notably from higher product-development and regulatory costs and freight, delivery and warehousing expenses.
- Interest expense net of capitalized interest was $0.7 million, versus $0.7 million in the prior-year quarter; the effective interest rate was 4.6%, compared with 4.1%. The prior-year results included a $0.5 million debt-extinguishment charge, absent in Q1 2012. The effective tax rate was 36.3%, versus 36.5%.
Balance sheet, cash flow and liquidity
- At March 31, cash was $14.7 million, down from $35.1 million at year-end 2011. Current assets were $192.9 million and current liabilities $95.3 million, a current ratio of approximately 2.0.
- Total debt was $58.4 million, down from $66.4 million at December 31, 2011; cash less total debt was approximately $(43.7) million. Stockholders’ equity was $195.9 million.
- Operating cash use reflected seasonal growth in receivables and other working-capital movements, partly offset by net income and increased accrued liabilities. The company used $5.7 million for capital spending, primarily to expand manufacturing capacity, and $7.6 million in financing activities, including debt principal and deferred acquisition-related payments.
- The company reported compliance with all senior credit-facility covenants and stated that covenant capacity permitted up to $75 million of additional borrowing. Substantially all assets are pledged as collateral. The credit facility matures in January 2016; an interest-rate swap covers $45 million of term-loan debt.
Material developments, outlook and risks
- Management provided no quantified full-year guidance in the filing. It noted that Q1 performance may not indicate full-year results. It reported working to improve availability of Impact herbicide for the 2013 use season.
- Product-specific trends included strong granular soil insecticide sales, improved Mocap and Nemacur supply, and lower Bidrin sales due to channel inventory. Non-crop Dibrom sales fell 33%, with 2011 channel inventory and drought conditions cited as factors.
- PCNB registrations had been approved for major commercial uses after a court vacated the EPA’s 2010 stop-sale order. Discussions with the agency continued on minor uses and existing-stock labeling/disposition. At quarter-end, PCNB inventory was $19.9 million and related intangible assets $5.1 million; the company said any loss was not then probable or reasonably estimable.
- Approximately 100 DBCP-related lawsuits were pending. A California action included 2,939 plaintiffs; the company said it intended to contest the claims and had not accrued a loss because it did not consider loss probable or reasonably estimable. A separate Delaware case was also contested without an accrual. The company described a separate California property-damage and injury matter as expected to be dismissed following a settlement by the remaining named defendant.
- Risks identified include changes in product demand, weather, regulation, competition and pricing, foreign-exchange movements, product-development and commercialization challenges, supply or capacity constraints, and access to capital. Management said there were no material changes to the risk factors in its 2011 Form 10-K. Disclosure controls were assessed as effective, with no material quarterly change in internal control over financial reporting.
Important facts for investors to verify
- Whether elevated crop demand, favorable conditions and soil-insecticide sales persist through the full growing season, and how channel inventories affect Bidrin and Dibrom.
- Receivables and accrued program-cost movements, seasonal operating cash use, and the planned manufacturing-capacity spending.
- PCNB regulatory developments and potential exposure to the carrying value of related inventory and intangible assets.
- Developments in DBCP litigation, including plaintiff exposure and the outcomes of pending dismissal motions; no loss accrual was recorded for the described matters.
- Debt covenant headroom, collateral obligations, interest-rate exposure and the company’s ability to maintain liquidity while funding seasonal working capital and investment.